SUMMARY In the Statin Therapies for Elevated Lipid Levels compared Across doses to
Rosuvastatin (STELLAR) trial, the efficacy of rosuvastatin calcium (Crestor) was compared …

Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high
cardiovascular risk patients in real outpatient practice. Material and methods. Patients≥ 30 …

Background Despite the demonstrated benefits of low-density lipoprotein cholesterol (LDL-
C) reduction in reducing the risk of coronary heart disease, many patients receiving lipid …

POLARIS investigated the efficacy and safety of rosuvastatin 40mg and atorvastatin 80mg in
high-risk patients with hypercholesterolemia. Patients (n= 871) were randomized to …

The aim of this multi-center, open-label, randomized, parallel-group trial was to compare the
efficacy of rosuvastatin with that of simvastatin in achieving the 1998 European …

Background Rosuvastatin calcium (CRESTOR®) has demonstrated superior efficacy in
reducing low-density lipoprotein cholesterol (LDL-C). However, healthcare providers and …

Methods—Discovery Belux is an open-label, multicentre, randomised, phase IIIb, parallel
group study comparing the efficacy of rosuvastatin (RSV) and atorvastatin (ATV) on changes …

The aim of this article is to examine the benefit-risk profile of rosuvastatin at doses of 10 to
40 mg. In dyslipidemic patients, rosuvastatin produced markedly greater reductions in low …

Background: Assessments of the effectiveness and cost-effectiveness of treatment with
statins in highrisk patients in routine clinical practice are needed. The objective of the …

The benefit from statin therapy is proportional to the low-density lipoprotein (LDL)
cholesterol reduction. However, adverse events appear to be related to dose rather than …